Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Apellis Pharmaceuticals, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 263
- −35 vs. Q1 2024
- Shares held
- 115.4M
- +2.41M (+2.1%) vs. Q1 2024
- Total value
- $4.43B
- −$2.21B (−33.3%) vs. Q1 2024
- New holders
- 32
- 127 more added
- Sold out
- 67
- 66 more reduced
4 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APLS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $10.2K |
| Q1 2026 | 324 | $5.56B |
| Q4 2025 | 280 | $3.17B |
| Q3 2025 | 273 | $2.77B |
| Q2 2025 | 247 | $2.28B |
| Q1 2025 | 255 | $2.80B |
| Q4 2024 | 260 | $4.04B |
| Q3 2024 | 265 | $3.41B |
| Q2 2024 | 263 | $4.43B |
| Q1 2024 | 302 | $6.65B |
| Q4 2023 | 284 | $6.82B |
| Q3 2023 | 256 | $4.34B |
| Q2 2023 | 317 | $9.71B |
| Q1 2023 | 282 | $7.28B |
| Q4 2022 | 244 | $5.20B |
| Q3 2022 | 250 | $6.66B |
| Q2 2022 | 212 | $4.15B |
| Q1 2022 | 212 | $4.62B |
| Q4 2021 | 187 | $3.83B |
| Q3 2021 | 181 | $2.29B |
| Q2 2021 | 205 | $4.08B |
| Q1 2021 | 175 | $2.80B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Apellis Pharmaceuticals, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 160,228 | $6.15M | 0.00% | +15,193+10.5% | Added |
| Schroder Investment Management Group | 168,403 | $6.46M | 0.01% | +128,000+316.8% | Added |
| California Public Employees Retirement System | 173,574 | $6.66M | 0.00% | +27,741+19.0% | Added |
| Macquarie Group Ltd | 184,931 | $7.09M | 0.01% | −36,723−16.6% | Reduced |
| 683 Capital Management, LLC | 186,000 | $7.13M | 0.75% | −29,000−13.5% | Reduced |
| Woodline Partners LP | 187,000 | $7.17M | 0.07% | +20.0% | Added |
| Balyasny Asset Management LLC | 199,954 | $7.67M | 0.02% | −32,289−13.9% | Reduced |
| Jane Street Group, LLC | 200,889 | $7.71M | 0.01% | +71,880+55.7% | Added |
| Capital Fund Management S.A. | 201,487 | $7.73M | 0.09% | +201,487 | New |
| Millennium Management LLC | 205,911 | $7.90M | 0.01% | −579,485−73.8% | Reduced |
| UBS Asset Management Americas Inc | 208,184 | $7.99M | 0.00% | +68,859+49.4% | Added |
| Eventide Asset Management, LLC | 209,794 | $8.05M | 0.14% | 00.0% | Unchanged |
| Barclays PLC | 216,878 | $8.32M | 0.00% | +191,086+740.9% | Added |
| Franklin Resources Inc | 225,932 | $8.67M | 0.00% | −717−0.3% | Reduced |
| Standard Life Aberdeen plc | 236,724 | $9.08M | 0.02% | +46,911+24.7% | Added |
| AQR Capital Management LLC | 246,880 | $9.18M | 0.01% | +190,420+337.3% | Added |
| Fiduciary Trust Co | 240,286 | $9.22M | 0.14% | −700−0.3% | Reduced |
| Rafferty Asset Management, LLC | 241,982 | $9.28M | 0.03% | +93,181+62.6% | Added |
| Prudential Financial Inc | 245,260 | $9.41M | 0.01% | −300−0.1% | Reduced |
| Pictet Asset Management Holding SA | 253,048 | $9.71M | 0.01% | −820,186−76.4% | Reduced |
| UBS Group AG | 272,397 | $10.4M | 0.00% | +161,105+144.8% | Added |
| Nuveen Asset Management, LLC | 280,001 | $10.7M | 0.00% | +9,425+3.5% | Added |
| TD Asset Management Inc | 311,832 | $12.0M | 0.01% | −147,570−32.1% | Reduced |
| Vestal Point Capital, LP | 335,000 | $12.9M | 0.96% | +110,000+48.9% | Added |
| Bank of New York Mellon Corp | 345,195 | $13.2M | 0.00% | +22,273+6.9% | Added |
| Logos Global Management LP | 400,000 | $15.3M | 1.77% | −400,000−50.0% | Reduced |
| Caption Management, LLC | 430,000 | $16.5M | 1.75% | +399,000+1,287.1% | Added |
| New York State Common Retirement Fund | 431,113 | $16.5M | 0.02% | +105,187+32.3% | Added |
| Bellevue Group AG | 444,404 | $17.0M | 0.28% | −29,511−6.2% | Reduced |
| Victory Capital Management Inc | 461,866 | $17.7M | 0.02% | −30,031−6.1% | Reduced |
| Northern Trust Corp | 462,218 | $17.7M | 0.00% | +21,762+4.9% | Added |
| Susquehanna International Group, LLP | 478,963 | $18.4M | 0.03% | +234,702+96.1% | Added |
| Candriam Luxembourg S.C.A. | 543,035 | $20.8M | 0.13% | −41,890−7.2% | Reduced |
| Braidwell LP | 611,800 | $23.5M | 0.74% | +611,800 | New |
| Voloridge Investment Management, LLC | 689,108 | $26.4M | 0.10% | +689,108 | New |
| Assenagon Asset Management S.A. | 734,708 | $28.2M | 0.07% | −1,288,906−63.7% | Reduced |
| Eagle Asset Management Inc | 802,253 | $29.1M | 0.16% | −43,280−5.1% | Reduced |
| Ameriprise Financial Inc | 783,914 | $30.1M | 0.01% | +252,552+47.5% | Added |
| Charles Schwab Investment Management Inc | 947,034 | $36.3M | 0.01% | +22,472+2.4% | Added |
| Bank of America Corp | 995,069 | $38.2M | 0.00% | +271,625+37.5% | Added |
| Polar Capital Holdings Plc | 1,079,440 | $41.4M | 0.24% | +25,000+2.4% | Added |
| Norges Bank | 1,079,605 | $41.4M | 0.01% | +71,685+7.1% | Added |
| Invesco Ltd. | 1,102,833 | $42.3M | 0.01% | +340,718+44.7% | Added |
| Price T Rowe Associates Inc | 1,276,426 | $49.0M | 0.01% | −1,182,820−48.1% | Reduced |
| OrbiMed Advisors LLC | 1,302,800 | $50.0M | 1.07% | +5,000+0.4% | Added |
| Fiera Capital Corp | 1,401,190 | $53.7M | 0.17% | +452,753+47.7% | Added |
| Artal Group S.A. | 1,467,080 | $56.3M | 1.44% | +151,798+11.5% | Added |
| Boxer Capital, LLC | 1,726,000 | $66.2M | 3.49% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,787,917 | $68.6M | 0.01% | +98,027+5.8% | Added |
| Deutsche Bank AG | 1,842,042 | $70.7M | 0.03% | +230,269+14.3% | Added |
| Morgan Stanley | 2,118,897 | $81.3M | 0.01% | +481,279+29.4% | Added |
| Deep Track Capital, LP | 2,500,000 | $95.9M | 2.86% | +1,500,000+150.0% | Added |
| Octagon Capital Advisors LP | 2,880,880 | $110.5M | 18.23% | +73,900+2.6% | Added |
| JPMorgan Chase & Co | 3,177,470 | $121.9M | 0.01% | +963,161+43.5% | Added |
| FMR LLC | 3,299,790 | $126.6M | 0.01% | +1,121,048+51.5% | Added |
| Jennison Associates LLC | 3,591,416 | $137.8M | 0.09% | +350,903+10.8% | Added |
| T. Rowe Price Investment Management, Inc. | 4,048,412 | $155.3M | 0.10% | −557,309−12.1% | Reduced |
| State Street Corp | 4,146,694 | $159.1M | 0.01% | +1,237,166+42.5% | Added |
| BlackRock Inc. | 5,795,272 | $222.3M | 0.01% | +300,681+5.5% | Added |
| Vanguard Group Inc | 9,809,552 | $376.3M | 0.01% | +303,686+3.2% | Added |
| Avoro Capital Advisors LLC | 11,111,111 | $426.2M | 5.68% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 11,607,425 | $445.3M | 13.64% | +250,000+2.2% | Added |
| Wellington Management Group LLP | 16,388,697 | $628.7M | 0.11% | +1,330,626+8.8% | Added |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −885,165−100.0% | Sold out |
| Iron Triangle Partners LP | 0 | $0 | 0.00% | −550,000−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −503,039−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −287,277−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −267,823−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −248,483−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −171,873−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Redmile Group, LLC | 0 | $0 | 0.00% | −155,000−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Senator Investment Group LP | 0 | $0 | 0.00% | −140,000−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −71,463−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −68,575−100.0% | Sold out |
| Lord, Abbett & Co. LLC | 0 | $0 | 0.00% | −54,000−100.0% | Sold out |
| Axiom Investors LLC | 0 | $0 | 0.00% | −50,770−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −38,024−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −36,994−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −35,092−100.0% | Sold out |
| Polar Asset Management Partners Inc. | 0 | $0 | 0.00% | −32,200−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −24,825−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −20,057−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −11,180−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −10,694−100.0% | Sold out |
| Neuberger Berman Group LLC | 0 | $0 | 0.00% | −10,675−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −10,415−100.0% | Sold out |
| Harvest Management LLC | 0 | $0 | 0.00% | −10,300−100.0% | Sold out |
| Wynnefield Capital Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −9,825−100.0% | Sold out |
| Soros Fund Management LLCSuperinvestorSoros Fund Management | 0 | $0 | 0.00% | −8,948−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −8,562−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −8,481−100.0% | Sold out |
| Emerald Advisers, LLC | 0 | $0 | 0.00% | −7,751−100.0% | Sold out |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −7,700−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −6,900−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −6,867−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −6,431−100.0% | Sold out |